Wells Fargo keeps Amgen at equal weight; raises price target to $435
Wells Fargo maintained an equal-weight rating on Amgen and raised its price target to $435.00 per share from $400.00,
Ratings actions GMT) Amgen Price Target Raised to $435.00/Share From $400.00 by Wells FargoRatings actions